Suven Pharmaceuticals Limited

NSEI:SUVENPHAR Voorraadrapport

Marktkapitalisatie: ₹324.4b

Suven Pharmaceuticals Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Sudhir Singh

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO1.2yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuur1.1yrs

Recente managementupdates

Recent updates

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Dec 15
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Aug 03
Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

May 12
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Mar 26
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

Mar 07
Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Nov 30
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Sep 03
Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Aug 04
Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

Jun 11
Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Apr 13
With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Mar 08
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Feb 08
Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

CEO

Sudhir Singh (59 yo)

1.2yrs

Tenure

Dr. Sudhir Kumar Singh, Ph.D. serves as Chief Executive Officer since September 29, 2023 at Suven Pharmaceuticals Ltd. He served as Chief Operating Officer of Aragen Life Sciences Private Limited from Sept...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Vivek Sharma
Executive Chairmanless than a yeargeen gegevensgeen gegevens
Sudhir Singh
Chief Executive Officer1.2yrsgeen gegevensgeen gegevens
Himanshu Agarwal
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Cyndrella Carvalho
Head of Investor Relationsno datageen gegevensgeen gegevens
Kundan Jha
Company Secretary & Compliance Officerless than a yeargeen gegevensgeen gegevens
Gaurav Bahadur
Chief Human Resources Officer1.2yrsgeen gegevensgeen gegevens
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorno datageen gegevensgeen gegevens
Subba Komaravolu
Chief Strategy Officer1.2yrsgeen gegevensgeen gegevens
Declan Ryan
Chief Commercial Officerless than a yeargeen gegevensgeen gegevens
Sunder Venkatraman
Vice President of Corporate Affairs3.8yrsgeen gegevensgeen gegevens

1.0yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SUVENPHAR wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Vivek Sharma
Executive Chairmanless than a yeargeen gegevensgeen gegevens
Vetukuri Venkata Naga Kali Vara Raju
MD & Director1.2yrsgeen gegevensgeen gegevens
Abhijit Mukherjee
Member of Advisory Council1.1yrsgeen gegevensgeen gegevens
Venkateswarlu Jasti
Member of Advisory Councilless than a year₹68.35mgeen gegevens
Shweta Jalan
Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Pankaj Patwari
Non-Executive Director1.2yrsgeen gegevensgeen gegevens
Vinod Rao
Independent Director1.2yrs₹1.36mgeen gegevens
Matangi Gowrishankar
Independent Director1.2yrs₹1.36mgeen gegevens
Stefan Stoffel
Member of Advisory Council1.1yrsgeen gegevensgeen gegevens
Pravin Udhyavara Rao
Independent Directorless than a year₹1.07mgeen gegevens
Vaidheesh Annaswamy
Vice-Chairperson of Advisory Councilless than a year₹27.27mgeen gegevens
Kumarapuram Ananthakrishnan
Independent Director1.2yrs₹1.36m0.000050%
₹ 162.2k

1.1yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SUVENPHAR wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.1 jaar), wat duidt op een nieuw bestuur.